FDA greenlights Siemens Healthineers’ 7T MRI for clinical use

In a first, the FDA has cleared a powerful 7-tesla MRI scanner for clinical use.

The machine getting the go-ahead, limited to exams of the head and extremities, is Siemens Healthineers’ Magnetom Terra.

In an Oct. 12 announcement, the agency says it gave the scanner the thumbs-up after reviewing the safety of its radiofrequency subsystem through simulations and computational modeling as well as experimental validation.

Further, Siemens supplied data from a study that compared the 7T machine’s images of 35 healthy patients against images of the same anatomic structures acquired with a predicate 3T device on the market.

“Board-certified radiologists reviewed the images and confirmed that the images acquired on the 7T device were of diagnostic quality and, in some cases, an improvement over imaging at the 3T,” the agency states.

Robert Ochs, PhD, of FDA’s Center for Devices and Radiological Health, adds that the more-than-doubled static magnetic field strength of 7T over 3T “allows for better visualization of smaller structures and subtle pathologies that may improve disease diagnosis.”

In a press release, Siemens says the scanner has a dual-mode feature that allows the operator to switch between a research mode and the newly 510(k)-cleared clinical mode while safely storing research data and clinical images on separate databases.

Click here for the approval announcement from FDA and here to read the Siemens press release.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.